TTL partners in major new EU Nanotechnology Grant


ELISHA - a major Grant in the new EU FP6 programme was started on 1st Jan 2004. TTL is a full partner and Dr Tim Gibson has been appointed as project manager.

ELISHA - which stands for: Electro-Immunointerfaces and Surface nanobiotechnology: a Heterodoxical Approach, is a nanoscience / nanotechnology project aimed at producing antibody based immunosensors that require no additional labels for detection of analytes, leading to a technology platform in immunosensing. The project aims to deliver a prototype instrument as the major deliverable.

The ELISHA website is available on and a direct link can be found on the Links page on this site.